نتایج جستجو برای: تومور مارکر ca125

تعداد نتایج: 5813  

2015
Longyu Zhang Ying Liu Yuping Xu Huan Wu Zhaolian Wei Yunxia Cao

BACKGROUND To investigate the expression of Beclin-1 mRNA and protein in eutopic and ectopic endometrium of women with and without endometriosis, and evaluate the association of Beclin-1 protein expression and serum CA125 levels in the endometriosis group due to CA125 being a well-known biomarker of endometriosis. MATERIALS AND METHODS The expression levels (mean ± SD) of the mRNA and protein...

2015
Tao Chen Min-Gui Zhang Hua-Xiang Xu Wen-Quan Wang Liang Liu Xian-Jun Yu Raj Kumar.

Serum carbohydrate antigen 19-9 (CA19-9) is widely used to predict the prognosis for pancreatic ductal adenocarcinoma (PDAC). However, hyperbilirubinemia and the CA19-9 nonsecretor phenotype restrict the usage of serum CA19-9 alone. The goal of this study was to confirm the prognostic role of preoperative serum CA125 in PDAC, especially in patients with jaundice.A total of 211 patients with res...

2011
Sonoo Mizuiri Hiromichi Hemmi Michitsune Arita Reibin Tai Yoshinari Hattori Atsuhiko Muto Yasunori Suzuki Yasushi Ohashi Ken Sakai Atsushi Aikawa

Objectives. Epithelial mesenchymal transition (EMT) is important for peritoneal deterioration. We evaluated the association between peritoneal solute transport rate (PSTR) and effluent markers related to EMT with adjusted values for effluent cancer antigen 125 (CA125). Methods. One hundred five incident peritoneal dialysis (PD) patients on PD for 25 (12-68) months with biocompatible solutions w...

2016
Song Zhao Yu Mei Jianli Wang Kai Zhang Rong Ma

BACKGROUND The aim of this study was to assess the diagnostic values of three breast tumor markers (i.e., CEA, CA153 and CA125) in milk and nipple discharge in the prediction of different breast diseases diagnoses. METHODS Three hundred thirty-six patients (96 breast cancer and 240 benign disease patients) with nipple discharge and a control group of 56 healthy parturient participants were en...

Journal: :The oncologist 1997
Eagle Ledermann

Epithelial ovarian cancer is the most common ovarian malignancy. CA125, the glycoprotein defined by the antibody OC 125, is the most important clinical marker for the diagnosis, treatment and follow-up of epithelial ovarian cancer. However, like most tumor markers, it is neither wholly specific nor sensitive for the disease. We discuss how CA125 in combination with other tests can be used in th...

Journal: :Interactive cardiovascular and thoracic surgery 2010
Taichiro Goto Arafumi Maeshima Yoshitaka Oyamada Ryoichi Kato

The patient was a 59-year-old woman in whom computed tomography revealed a posterior mediastinal cyst and ovarian cystoma at a medical check-up in March 2007. Blood tests showed high CA19-9 and CA125 levels. She underwent left adnexectomy for ovarian cystoma in July 2008 and histopathological examination led to a diagnosis of dermoid cyst. The postoperative levels of CA19-9 and CA125 remained h...

2015
Oleg Blyuss Alex Gentry-Maharaj Evangelia-Orania Fourkala Andy Ryan Alexey Zaikin Usha Menon Ian Jacobs John F. Timms

Early detection of ovarian cancer through screening may have impact on mortality from the disease. Approaches based on CA125 cut-off have not been effective. Longitudinal algorithms such as the Risk of Ovarian Cancer Algorithm (ROCA) to interpret CA125 have been shown to have higher sensitivity and specificity than a single cut-off. The aim of this study was to investigate whether other ovarian...

Background: Ovarian carcinoma is one of the leading causes of cancer-related death among females. K-ras codon 12 mutations are commonly occurring mutations in different types of cancers and leads to resistance against anti-EGFR therapeutics. Hence, determination of mutations in k-ras gene is crucial for predicting response to anti-EGFR therapies. This study aimed to evaluate the prevalence of k...

Afsaneh Tehranian, Akram Ghahghaei-Nezamabadi, Khadije Maajaani, Maryam Ganjeh, Nasim Yarmohammadi, Reihaneh Aghajani,

Background: Ovarian cancer is the fifth leading cancer-related cause of death in women worldwide and is often diagnosed at advanced stages. Regarding the low sensitivity and specificity of the currently available diagnostic techniques, in the present study, we aimed to evaluate the accuracy of RMI and ROMA indexes and comparing these two indexes with CA-125 and HE4 parameters for the diagnosis ...

Journal: :The Lancet 2010
Gordon JS Rustin Maria EL van der Burg Clare L Griffin David Guthrie Alan Lamont Gordon C Jayson Gunnar Kristensen César Mediola Corneel Coens Wendi Qian Mahesh KB Parmar Ann Marie Swart

BACKGROUND Serum CA125 concentration often rises several months before clinical or symptomatic relapse in women with ovarian cancer. In the MRC OV05/EORTC 55955 collaborative trial, we aimed to establish the benefits of early treatment on the basis of increased CA125 concentrations compared with delayed treatment on the basis of clinical recurrence. METHODS Women with ovarian cancer in comple...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید